1. Home
  2. P110α
  Subject:

P110α   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Gene  5 times
Breast cancer  5 times
Prime Time Entertainment Network  4 times
Kinase  4 times
KRAS  4 times
Carcinoma  4 times
Phosphoinositide 3-kinase  3 times
P53  3 times
Neu!  3 times
Estrogen receptor  3 times
Colorectal cancer  3 times
BRAF (gene)  3 times
Trastuzumab  2 times
Polymerase chain reaction  2 times
Mechanistic target of rapamycin  2 times
Immunohistochemistry  2 times
Genome  2 times
Exon  2 times
Everolimus  2 times
Enzyme inhibitor  2 times
Biopsy  2 times
Bevacizumab  2 times
Beta-catenin  2 times
Adenocarcinoma  2 times
Vagina  1 time
Urinary system  1 time
The Cancer Genome Atlas  1 time
Targeted therapy  1 time
Stomatitis  1 time
Stomach cancer  1 time
Somatic cell  1 time
Sirolimus  1 time
Sensitivity analysis  1 time
SNP array  1 time
Receptor tyrosine kinase  1 time
Random effects model  1 time
Publication bias  1 time
PubMed  1 time
Protein kinase B  1 time
Protein  1 time
Progression-free survival  1 time
Progesterone receptor  1 time
Phosphatidylinositol  1 time
Phenotype  1 time
Performance status  1 time
Peptide  1 time
Pearson product-moment correlation coefficient  1 time
Pancreatic cancer  1 time
Paclitaxel  1 time
Neoadjuvant therapy  1 time
Mutation  1 time
Munhwa Broadcasting Corporation  1 time
Multivariate analysis  1 time
Metastasis  1 time
MAPK/ERK pathway  1 time
MAP2K1  1 time
Luminex Corporation  1 time
Indole  1 time
Independent Community and Health Concern  1 time
Idiopathic pulmonary fibrosis  1 time
Hormone  1 time
Growth factor  1 time
Fibrosis  1 time
Exome sequencing  1 time
Estrogen  1 time
Epithelium  1 time
Embase  1 time
Eastern Cooperative Oncology Group  1 time
Diarrhea  1 time
DNA sequencing  1 time
DNA polymerase  1 time
DNA microarray  1 time
DNA  1 time
Cyclin D1  1 time
Crizotinib  1 time
Cholangiocarcinoma  1 time
Chemotherapy  1 time
Carboplatin  1 time
Blood plasma  1 time
Biomarker  1 time
Biochemical cascade  1 time
Ant colony  1 time
Anaplastic lymphoma kinase  1 time
Allele  1 time
Agar  1 time
AKT1  1 time

Publications tagged with this subject: 14

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Detection of PIK3CA Mutations in Plasma DNA of Colorectal Cancer Patients by an Ultra-Sensitive PNA-Mediated PCR

2. Non-invasive papillary urothelial carcinoma of the vagina: molecular analysis of a rare case identifies clonal relationship to non-invasive urothelial carcinoma of the bladder

3. No significant association between PIK3CA mutation and survival of esophageal squamous cell carcinoma: A meta-analysis

4. Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses

5. PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

6. Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

7. Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging

8. Identification of frequent somatic mutations in inflammatory breast cancer

9. System Biology Approach to Identify Potential Receptor for Targeting Cancer and Biomolecular Interaction Studies of Indole[2,1-a]Isoquinoline Derivative as Anticancerous Drug Candidate Against it

10. PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity

11. Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer

12. Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies

13. Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy

14. Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer


Questions?

Drop us a message.